CIK 0001746473 · Non-accelerated filer<br>Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474272481
- Phone
- 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 90 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-14 | Cummings Keith Lamont Chief Financial Officer | Grant or award | +38,750 | 223,770 | ||
| 2023-07-14 | Coulie Bernard President and CEO | Grant or award | +137,500 | 412,253 | ||
| 2023-06-13 | Cummings Keith Lamont Chief Financial Officer | Option exercise | +30,750 | $2.08 | $64K | 185,020 |
| 2023-06-13 | Cummings Keith Lamont Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −30,750 | 97,047 | ||
| 2023-06-09 | Cummings Keith Lamont Chief Financial Officer | Option exercise | +5,800 | $2.08 | $12K | 154,270 |
| 2023-06-09 | Cummings Keith Lamont Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −5,800 | 127,797 | ||
| 2023-06-07 | Shah Smital Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2023-06-07 | PYOTT DAVID E I Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2023-06-07 | MCCOURT Thomas A Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2023-06-07 | Knobil Katharine Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2023-06-07 | Huh Hoyoung Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2023-06-07 | Curnutte John T Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2023-06-07 | CROWELL GAYLE A Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2023-06-07 | Cline Darren S Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2023-06-07 | Bruhn Suzanne Louise Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2023-04-03 | Ouimette Mike General Counsel & Corp. Sec'y | Sale 10b5-1 | −2,677 | $26.74 | $72K | 50,989 |
| 2023-04-03 | Ouimette Mike General Counsel & Corp. Sec'y | Sale 10b5-1 | −200 | $27.46 | $5K | 50,789 |
| 2023-03-30 | Ouimette Mike General Counsel & Corp. Sec'y | Sale 10b5-1 | −4,874 | $26.52 | $129K | 53,666 |
| 2023-03-30 | Lefebvre Eric Chief Medical Officer | Sale 10b5-1 | −11,245 | $26.52 | $298K | 145,786 |
| 2023-03-30 | Hull Hans Chief Business Officer | Sale 10b5-1 | −9,036 | $26.52 | $240K | 201,964 |
Page 8 of 8 · 160 trades